Breast cancer: An Overview | ||
| Records of Pharmaceutical and Biomedical Sciences | ||
| Volume 8, Issue 1, 2024, Pages 255-262 PDF (344.57 K) | ||
| Document Type: Mini-reviews | ||
| DOI: 10.21608/rpbs.2024.347689.1346 | ||
| Authors | ||
| Ranza Ahmed Elrayess* 1; Wessal Abdel Latif2; Safia Messaoudi2; Fatma Mostafa3 | ||
| 1Department of Pharmaceutical organic chemistry, faculty of pharmacy, Suez canal University, Ismailia, Egypt | ||
| 2Molecular Genetics Department, College of Forensic Sciences, Naif Arab University for Security Sciences, Riyadh, Saudi Arabia. | ||
| 3Microbiology Department, College of Pharmacy, Al-Ayen Iraqi University, Dhi-Qar, 64001, Iraq | ||
| Abstract | ||
| Breast cancer is a prevailing disease worldwide that requires effective and rational therapy. For this purpose, the use of various treatment modalities should be optimized according to the stage of disease and the risk: benefit ratio of the therapeutic agents employed in the patients. Although the therapies involved provide reduction in morbidity and mortality rates, monitoring is required to combat the resulting adverse drug reactions. This review would be helpful for healthcare professionals to address the multi factorial disease in accordance with its occurrence thereby providing rationalized therapy to the patients.Cancer is considered as a complex disease, which includes the changes in cell physiology, which ultimately lead to malignant tumors (Seyfried and Shelton, 2010). Cancer can result from abnormal differentiation of any of the different types of cells in the body, so there are hundreds of the same types of cancers which can differ substantially in their behavior and response to treatment | ||
| Keywords | ||
| Breast cancer; Chemotherapy; Endocrine therapy; Adjuvant therapy | ||
|
Statistics Article View: 96 PDF Download: 56 |
||
